Comparing Traditional and Biofeedback Telepractice Treatment for Residual Speech Errors

Completed · Phase 1

Conditions studied: Speech Sound Disorder

In brief

This study aims to evaluate the relative efficacy of biofeedback and traditional treatment for residual speech errors when both are delivered via telepractice. In a single-case randomization design, up to eight children with RSE will receive both visual-acoustic biofeedback and traditional treatment via telepractice. Acoustic measures of within-session change will be compared across sessions randomly assigned to each condition. It is hypothesized that participants will exhibit a clinically significant overall treatment response and that short-term measures of change will indicate that biofeedback is associated with larger increments of progress than traditional treatment.

Key facts

Study ID

NCT04625062

Run by

New York University

People needed

7

Starts

2020-09-01

Expected to finish

2021-03-18

Last updated by the study team

2023-02-13

Who can join

Age: 9 and older, up to 15. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be between 9;0 and 15;11 years of age at the time of enrollment.
• Must speak English as the dominant language (i.e., must have begun learning English by age 2, per parent report).
• Must speak a rhotic dialect of English.
• Must pass a brief examination of oral structure and function.
• Must exhibit less than thirty percent accuracy, based on trained listener ratings, on a probe list eliciting /r/ in various phonetic contexts at the word level.

You may not qualify if…

• Must not receive a T score more than 1.3 standard deviations (SD) below the mean on the Wechsler Abbreviated Scale of Intelligence-2 (WASI-2) Matrix Reasoning.
• Must not receive a scaled score below 6 on the CELF-5 Recalling Sentences or Formulated Sentences subtests.
• Must not have history of sensorineural hearing loss or failed infant hearing screening.
• Must not have an existing diagnosis of developmental disability, major neurobehavioral syndrome such as cerebral palsy, Down Syndrome, or Autism Spectrum Disorder, or major neural disorder (e.g., epilepsy, agenesis of the corpus callosum) or insult (e.g., traumatic brain injury, stroke, or tumor resection).
• Must not show clinically significant signs of apraxia of speech or dysarthria.
• Must not have major orthodontia that could interfere with tongue-palate contact.

Where it is running

• Montclair State University — Bloomfield, New Jersey, United States
• Syracuse University — Syracuse, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.